FDA NDC Directory · JSON-LD · Markdown

Bivalirudin

NDC 70511-142 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerMAIA Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211215
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsBIVALIRUDIN (250 mg/1)
Marketing started20240527
Package count2

External sources

Source: openFDA. Public-domain (CC0).